Which statement best defines compliance in a treatment trial?

• A. The proportion of patients adherent to the prescribed treatment.
• B. The proportion of patients who receive any treatment at all.
• C. The rate of adverse events related to the treatment.
• D. The proportion of patients who complete the follow-up visits.

Answer: (A)

In a treatment trial, compliance (adherence) means how closely participants follow the prescribed regimen. It is best defined by the proportion of participants who take the treatment as prescribed, at the correct dose and schedule, for the duration specified by the protocol. This matters because the observed treatment effect depends on actual exposure; if many participants don’t adhere, the treatment may appear less effective than it truly is. In randomized trials, intention-to-treat analyses include everyone as randomized to preserve randomization, while analyses focusing on those who complied can show the effect under proper adherence, highlighting why measuring compliance is essential.

The other ideas describe different concepts: receiving any treatment at all refers to initial exposure or uptake, not adherence to the regimen; rate of adverse events relates to safety; completing follow-up visits pertains to retention.